R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Diana Al-Sarayfi; Frederik O. Meeuwes; Mujde Durmaz; Djamila E. Issa; Rolf E. Brouwer; Aart Beeker; Anna van Rhenen; Pim G. N. J. Mutsaers; Lara H. Bohmer; Marjolein W. M. van der Poel; Liane te Boome; Tom van Meerten; Martine E. D. Chamuleau; Josee M. Zijlstra; Mirian Brink; Marcel Nijland

doi:10.1038/s41408-022-00723-4

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Diana Al-Sarayfi, Frederik O. Meeuwes, Mujde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G. N. J. Mutsaers, Lara H. Bohmer, Marjolein W. M. van der Poel, Liane te Boome, Tom van Meerten, Martine E. D. Chamuleau, Josee M. Zijlstra, Mirian Brink, Marcel Nijland^*

^*Corresponding author voor dit werk

Onderzoeksoutput: Letter › Academic › peer review

2 Citaten (Scopus)

254 Downloads (Pure)

Originele taal-2	English
Artikelnummer	125
Aantal pagina's	4
Tijdschrift	Blood cancer journal
Volume	12
Nummer van het tijdschrift	9
DOI's	https://doi.org/10.1038/s41408-022-00723-4
Status	Published - 2-sep.-2022

Toegang tot document

10.1038/s41408-022-00723-4Licentie: CC BY

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphomaFinal publisher's version, 594 KBLicentie: CC BY

Handle.net

Permanente koppeling

Citeer dit

Al-Sarayfi, D., Meeuwes, F. O., Durmaz, M., Issa, D. E., Brouwer, R. E., Beeker, A., van Rhenen, A., Mutsaers, P. G. N. J., Bohmer, L. H., van der Poel, M. W. M., te Boome, L., van Meerten, T., Chamuleau, M. E. D., Zijlstra, J. M., Brink, M., & Nijland, M. (2022). R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma. Blood cancer journal, 12(9), Artikel 125. https://doi.org/10.1038/s41408-022-00723-4

@article{410a767d8aa74fc1a26490c5c7657fa8,

title = "R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma",

keywords = "ELDERLY-PATIENTS",

author = "Diana Al-Sarayfi and Meeuwes, {Frederik O.} and Mujde Durmaz and Issa, {Djamila E.} and Brouwer, {Rolf E.} and Aart Beeker and {van Rhenen}, Anna and Mutsaers, {Pim G. N. J.} and Bohmer, {Lara H.} and {van der Poel}, {Marjolein W. M.} and {te Boome}, Liane and {van Meerten}, Tom and Chamuleau, {Martine E. D.} and Zijlstra, {Josee M.} and Mirian Brink and Marcel Nijland",

year = "2022",

month = sep,

day = "2",

doi = "10.1038/s41408-022-00723-4",

language = "English",

volume = "12",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "9",

}

Al-Sarayfi, D, Meeuwes, FO, Durmaz, M, Issa, DE, Brouwer, RE, Beeker, A, van Rhenen, A, Mutsaers, PGNJ, Bohmer, LH, van der Poel, MWM, te Boome, L, van Meerten, T, Chamuleau, MED, Zijlstra, JM, Brink, M & Nijland, M 2022, 'R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma', Blood cancer journal, vol. 12, nr. 9, 125. https://doi.org/10.1038/s41408-022-00723-4

TY - JOUR

T1 - R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

AU - Al-Sarayfi, Diana

AU - Meeuwes, Frederik O.

AU - Durmaz, Mujde

AU - Issa, Djamila E.

AU - Brouwer, Rolf E.

AU - Beeker, Aart

AU - van Rhenen, Anna

AU - Mutsaers, Pim G. N. J.

AU - Bohmer, Lara H.

AU - van der Poel, Marjolein W. M.

AU - te Boome, Liane

AU - van Meerten, Tom

AU - Chamuleau, Martine E. D.

AU - Zijlstra, Josee M.

AU - Brink, Mirian

AU - Nijland, Marcel

PY - 2022/9/2

Y1 - 2022/9/2

KW - ELDERLY-PATIENTS

U2 - 10.1038/s41408-022-00723-4

DO - 10.1038/s41408-022-00723-4

M3 - Letter

SN - 2044-5385

VL - 12

JO - Blood cancer journal

JF - Blood cancer journal

IS - 9

M1 - 125

ER -